Paris (AFP) – The near 40-year quest for an AIDS vaccine received a hopeful boost Saturday when scientists announced that a trial drug triggered an immune response in humans and shielded monkeys from infection. Scientists announced that a trial drug against the AIDS vaccine has yielded encouraging results and has advanced to the next phase...
Tag: <span>Vaccine</span>
Post
Brain cancer vaccine effective in some patients
Most people with the deadly brain cancer glioblastoma die less than 18 months after diagnosis. But a multicenter clinical trial of a personalized vaccine that targets aggressive cancer has indicated improved survival rates for such patients. The study appears May 29 in the Journal of Translational Medicine. The phase three clinical trial included 331 patients at over 80 sites...
Post
A mix of Viagra and the flu vaccine could treat cancer: Bizarre cocktail is now being tested in humans after reducing the disease by 90% in mice
Erectile dysfunction drugs block suppressor cells, which allows natural killer cells to do their cancer-fighting job The flu vaccine further invigorates the natural killer cells, they found A combination of Viagra and a flu vaccine could treat cancer, surprising new research suggests. The unconventional strategy invigorates the immune system to attack tumor cells left lingering after surgery, when...
Post
Biomarkers and efficacy of vaccine responses among patients treated with new MS drug
Penn Medicine neurologist presents latest ocrelizumab research at American Academy of Neurology Annual Meeting LOS ANGELES – In March 2017, the U.S. Food and Drug Administration approved ocrelizumab as the first treatment for both relapsing (RMS) and progressive forms of multiple sclerosis (MS), a genetic disease that afflicts approximately 400,000 Americans with an estimated 10,000 new cases...
Post
Technology holds personalised cancer vaccine breakthrough
The attack of a tumor cell made by white blood cells of the patient (lymphocytes) generated by cancer vaccines. Credit: University of Queensland University of Queensland researchers have developed a vaccine delivery technology that enables treatment to be tailored precisely for different cancers. UQ’s Professor Ranjeny Thomas said the technology had the potential to improve...
Post
Researchers develop exciting new vaccine adjuvant
Associate Professors Bridget Stocker and Mattie Timmer from the School of Chemical and Physical Sciences worked with scientists from Japan to develop an adjuvant which can kick-start a powerful immune response and trigger a specific type of T-cell response. Adjuvants are substances that improve the body’s immune response to an antigen. Current vaccines tend to...
Post
Could this jab STOP genital herpes? Scientists create ‘most effective ever’ vaccine to control spread of the STI
More than 500 million people have genital herpes, or HSV2 But no vaccine candidate has ever stood up to pre-clinical trials Now a new three-pronged formula has protected monkeys from transmission It means human trials are likely, paving the way to a publicly-available vaccine The first ever effective genital herpes vaccine has succeeded in...
Post
Vaccine Shows Promising Results for Early-Stage Breast Cancer Patients
TAMPA, Fla. – Immunotherapy is a fast growing area of cancer research. It involves developing therapies that use a patient’s own immune system to fight and kill cancer. Moffitt Cancer Center is working on a new vaccine that would help early-stage breast cancer patients who have HER2 positive disease. The HER2 protein is overexpressed in nearly 25 percent...